Aligos Therapeutics (ALGS)
(Delayed Data from NSDQ)
$19.43 USD
+6.92 (55.32%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $18.78 -0.65 (-3.35%) 6:20 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Earnings News For ALGS
-
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results
-
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
-
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
-
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results
-
Aligos Therapeutics to Announce 3rd Quarter Results on November 2, 2023
-
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Results
-
Aligos Therapeutics to Announce Second Quarter Results on August 03, 2023
-
Aligos Therapeutics, Inc. (ALGS) Reports Q1 Loss, Lags Revenue Estimates
-
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2023 Financial Results
-
Aligos Therapeutics to Announce First Quarter Results on May 4, 2023
-
Aligos Therapeutics, Inc. (ALGS) Reports Q4 Loss, Tops Revenue Estimates
-
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2022 Financial Results
-
Aligos Therapeutics to Announce Fourth Quarter Results March 9, 2023
-
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2022 Financial Results
-
Aligos Therapeutics to Announce Third Quarter Results November 2, 2022